This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. AIKI, LUNA, DKDCA, ZJYL, OCX, MBOT, APYX, CLLS, BYSI, and ADAGShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include AIkido Pharma (AIKI), Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Jin Medical International (ZJYL), OncoCyte (OCX), Microbot Medical (MBOT), Apyx Medical (APYX), Cellectis (CLLS), BeyondSpring (BYSI), and Adagene (ADAG). Bioanalytical Systems vs. Its Competitors AIkido Pharma Luna Innovations Data Knights Acquisition Jin Medical International OncoCyte Microbot Medical Apyx Medical Cellectis BeyondSpring Adagene AIkido Pharma (NASDAQ:AIKI) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment. Which has higher earnings and valuation, AIKI or BASI? Bioanalytical Systems has higher revenue and earnings than AIkido Pharma. Bioanalytical Systems is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido PharmaN/AN/A-$7.17M-$3.88-1.29Bioanalytical Systems$60.47M0.37-$4.68M-$0.35-5.74 Do insiders and institutionals have more ownership in AIKI or BASI? 10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is AIKI or BASI more profitable? AIkido Pharma has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. AIkido Pharma's return on equity of -18.21% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Bioanalytical Systems -7.75%-42.74%-6.38% Does the media prefer AIKI or BASI? In the previous week, AIkido Pharma's average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score. Company Overall Sentiment AIkido Pharma Neutral Bioanalytical Systems Neutral Which has more risk and volatility, AIKI or BASI? AIkido Pharma has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. SummaryBioanalytical Systems beats AIkido Pharma on 6 of the 10 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.37M$28.72M$5.56B$9.09BDividend YieldN/AN/A5.06%4.02%P/E Ratio-4.79N/A28.2620.26Price / Sales0.370.25408.83152.10Price / Cash558.4057.2337.1257.67Price / Book2.910.268.045.49Net Income-$4.68M-$525K$3.19B$250.45M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$2.01-4.7%N/A-10.7%$22.37M$60.47M-4.79397AIKIAIkido PharmaN/A$5.10-3.2%N/A+159.9%$27.97MN/A-1.314Gap UpHigh Trading VolumeLUNALuna Innovations0.3528 of 5 stars$0.80-15.8%N/A-71.3%$27.17M$116.61M0.00390News CoverageGap DownDKDCAData Knights AcquisitionN/A$0.55-12.5%N/A-44.0%$2.85MN/A-2.902High Trading VolumeZJYLJin Medical InternationalN/A$0.58+1.0%N/A-77.5%$90.96M$23.50M0.00245News CoveragePositive NewsOCXOncoCyte1.9143 of 5 stars$3.18+16.3%$6.06+90.9%-4.7%$90.80M$3.84M-0.90120MBOTMicrobot Medical2.1232 of 5 stars$2.48-1.2%$9.00+262.9%+142.6%$90.22MN/A-3.8220Options VolumeAPYXApyx Medical2.0359 of 5 stars$2.37-8.1%N/A+52.2%$89.56M$48.10M-4.31270CLLSCellectis3.4357 of 5 stars$1.61+0.6%$4.00+148.4%-23.9%$89.48M$49.22M-1.87290BYSIBeyondSpringN/A$2.21-2.6%N/A-1.3%$89.11M$1.75M0.0080ADAGAdagene2.5983 of 5 stars$1.89-3.1%$8.00+323.3%-30.8%$89.04M$100K0.00260Gap Up Related Companies and Tools Related Companies AIkido Pharma Competitors Luna Innovations Competitors Data Knights Acquisition Competitors Jin Medical International Competitors OncoCyte Competitors Microbot Medical Competitors Apyx Medical Competitors Cellectis Competitors BeyondSpring Competitors Adagene Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.